ArticleFrontiers in oncology2026

Ceritinib efficacy in SMARCA4-deficient NSCLC harboring novel CTNND2 ALK/EML4-ALK fusion: case report.

Zhigang Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.